Scientists demonstrate a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. The research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.
Read more https://www.sciencedaily.com/releases/2023/09/230918153233.htm